Novartis AG-RegNVSEF
13F holders, Q1 2024 (March 31)3holders
$97.00avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Novartis AG-Reg (NVSEF) in their 13F filings. The largest holders were Boston Common Asset Management, LLC ($12.1M), Kennedy Capital Management LLC ($6.5M) and Promethos Capital, LLC ($135K).
- Company
- Novartis AG-Reg
- CUSIP
- H5820Q150
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $54.6M |
Ownership 3 holders
| Boston Common Asset Management, LLC | 0.29% | Reduce -2.5% | 125,076 | $12.1M |
| Kennedy Capital Management LLC | 0.13% | Add +190.1% | 67,028 | $6.5M |
| Promethos Capital, LLC | 0.08% | Reduce -74.2% | 1,391 | $135K |
"% of holder's portfolio" is NVSEF's weight in each manager's 13F, not the share of Novartis AG-Reg the manager owns.